12,514 Shares in Tenet Healthcare Co. (NYSE:THC) Purchased by Mirae Asset Global Investments Co. Ltd.

Mirae Asset Global Investments Co. Ltd. purchased a new stake in Tenet Healthcare Co. (NYSE:THC - Free Report) in the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund purchased 12,514 shares of the company's stock, valued at approximately $946,000.

A number of other hedge funds and other institutional investors have also bought and sold shares of the stock. Sunbelt Securities Inc. acquired a new position in Tenet Healthcare during the third quarter worth about $67,000. USA Financial Formulas acquired a new position in Tenet Healthcare during the third quarter worth about $92,000. CWM LLC raised its stake in Tenet Healthcare by 49.8% during the third quarter. CWM LLC now owns 1,443 shares of the company's stock worth $95,000 after acquiring an additional 480 shares in the last quarter. SG Americas Securities LLC bought a new stake in shares of Tenet Healthcare during the third quarter worth about $152,000. Finally, Neo Ivy Capital Management bought a new stake in shares of Tenet Healthcare during the third quarter worth about $155,000. Institutional investors and hedge funds own 95.44% of the company's stock.

Tenet Healthcare Trading Up 0.4 %

Shares of THC stock traded up $0.41 during trading hours on Wednesday, hitting $98.27. 911,040 shares of the company were exchanged, compared to its average volume of 1,132,196. The firm has a market cap of $9.75 billion, a P/E ratio of 17.21, a P/E/G ratio of 3.04 and a beta of 2.08. Tenet Healthcare Co. has a fifty-two week low of $51.04 and a fifty-two week high of $107.80. The company has a debt-to-equity ratio of 4.77, a quick ratio of 1.42 and a current ratio of 1.51. The company has a 50 day simple moving average of $97.96 and a two-hundred day simple moving average of $80.05.

Tenet Healthcare (NYSE:THC - Get Free Report) last issued its earnings results on Thursday, February 8th. The company reported $2.68 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $1.58 by $1.10. Tenet Healthcare had a return on equity of 26.34% and a net margin of 2.97%. The company had revenue of $5.38 billion for the quarter, compared to analysts' expectations of $5.28 billion. During the same period last year, the business earned $1.96 EPS. Tenet Healthcare's quarterly revenue was up 7.8% compared to the same quarter last year. Equities analysts anticipate that Tenet Healthcare Co. will post 6.3 EPS for the current year.

Insider Buying and Selling

In related news, Director Richard W. Fisher sold 2,100 shares of the stock in a transaction on Wednesday, February 14th. The stock was sold at an average price of $88.21, for a total value of $185,241.00. Following the transaction, the director now directly owns 20,127 shares in the company, valued at approximately $1,775,402.67. The sale was disclosed in a document filed with the SEC, which is available through the SEC website. In other Tenet Healthcare news, EVP Thomas W. Arnst sold 17,000 shares of the firm's stock in a transaction on Friday, March 1st. The stock was sold at an average price of $94.84, for a total transaction of $1,612,280.00. Following the transaction, the executive vice president now directly owns 8,148 shares in the company, valued at approximately $772,756.32. The sale was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, Director Richard W. Fisher sold 2,100 shares of the firm's stock in a transaction on Wednesday, February 14th. The shares were sold at an average price of $88.21, for a total value of $185,241.00. Following the transaction, the director now owns 20,127 shares in the company, valued at $1,775,402.67. The disclosure for this sale can be found here. Insiders have sold a total of 51,268 shares of company stock worth $4,944,810 in the last ninety days. Corporate insiders own 0.93% of the company's stock.

Analyst Ratings Changes

Several analysts have recently weighed in on the company. Cantor Fitzgerald restated an "overweight" rating and set a $104.00 price target on shares of Tenet Healthcare in a report on Wednesday, April 10th. Wolfe Research upgraded Tenet Healthcare from a "peer perform" rating to an "outperform" rating and set a $122.00 price target on the stock in a report on Wednesday, March 27th. Royal Bank of Canada boosted their price target on Tenet Healthcare from $97.00 to $109.00 and gave the stock an "outperform" rating in a report on Friday, February 9th. Deutsche Bank Aktiengesellschaft boosted their price target on Tenet Healthcare from $100.00 to $126.00 and gave the stock a "buy" rating in a report on Friday, April 12th. Finally, Barclays assumed coverage on Tenet Healthcare in a report on Wednesday, March 6th. They issued an "overweight" rating and a $113.00 target price on the stock. One equities research analyst has rated the stock with a hold rating, fifteen have issued a buy rating and one has assigned a strong buy rating to the company. According to data from MarketBeat, Tenet Healthcare currently has a consensus rating of "Buy" and a consensus target price of $100.38.

Tenet Healthcare Profile

Tenet Healthcare Corporation operates as a diversified healthcare services company in the United States. The company operates through two segments: Hospital Operations and Services, and Ambulatory Care. Its general hospitals offer acute care services, operating and recovery rooms, radiology and respiratory therapy services, clinical laboratories, and pharmacies.